Clinical Trial in China

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05580952

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Genesis Medtech Corporation (from the registry)
Registry
  • NCT NCT05580952
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05580952. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-14 (anticipated); primary completion 2023-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial in China
Condition
Diseases of Aortic Valve
Condition
Aortic Regurgitation Disease
Lead sponsor
Genesis Medtech Corporation (class: industry)

Record details

Record id
cardio:ct-nct05580952
Content hash
688b62aa934538a2c9c20df10423f915fe0aa5dc8339c58c882dcc095f6bdd3e